Linde PLC (LIN) Stock News

Class action lawsuits have been filed against four publicly-traded companies alleging materially false and misleading statements. Badger Meter is accused of pulling forward customer orders to conceal weakening demand. PicS failed to disclose credit quality deterioration and reclassified exposures. Verra Mobility concealed dependency on Avis contract extension. Grail misrepresented confidence in trial results. Investors have until August 4, 2026 (or July 27 for BMI) to file lead plaintiff motions.

A class action lawsuit has been filed against Graphic Packaging Holding Company for allegedly making false and misleading statements regarding inventory management issues, reduced demand, increased costs, and unreliable financial guidance for FY 2025. Investors who purchased securities between February 4, 2025 and February 2, 2026 have until July 6, 2026 to apply as lead plaintiff.

A federal securities class action has been filed against PicS N.V. (NASDAQ: PICS) alleging that the company and its executives made false and misleading statements in connection with its January 30, 2026 IPO. The lawsuit claims PicS concealed deficiencies in credit evaluation procedures discovered in December 2025, including the reclassification of R$590 million in exposures to its highest risk category and a Stage 3 formation rate exceeding 7%. Following the disclosure of these issues on March 18, 2026, PICS stock fell 22.5% from its $19.00 IPO price to $12.27. The deadline to seek lead plaintiff appointment is August 4, 2026.

A federal securities class action has been filed against FS KKR Capital Corp. (FSK) alleging that the company and its executives made false and misleading statements regarding portfolio restructuring effectiveness, investment valuations, and dividend sustainability. The lawsuit covers investors who purchased FSK stock between May 8, 2024 and February 25, 2026. The deadline to seek lead plaintiff appointment is July 3, 2026.

Rosen Law Firm announces a securities class action lawsuit against SES AI Corporation (NYSE: SES) for investors who purchased securities between January 29, 2025 and March 4, 2026. The lawsuit alleges that SES AI made materially false statements regarding business prospects, overstated expected results from deals, created artificial revenue through circular transactions, and failed to disclose material logistics constraints affecting Q4 2025 revenues and 2026 guidance. The lead plaintiff deadline is June 26, 2026.

A class action lawsuit has been filed against Babcock & Wilcox Enterprises, Inc. for allegedly making false and misleading statements regarding a Power Generation Contract with Applied Digital. The lawsuit claims the company's largest shareholder BRC Group Holdings stood on both sides of the deal and that Applied Digital may not have actually needed the products/services, raising questions about revenue recognition and overstated business prospects. Investors who purchased B&W securities between November 5, 2025 and March 11, 2026 can apply to be lead plaintiff by June 15, 2026.

A class action lawsuit has been filed against SES AI Corporation (NYSE:SES) for allegedly making false and misleading statements about its business prospects, including overstating expected results from deals, creating artificial revenue through circular transactions, and failing to disclose material logistics constraints that affected Q4 2025 revenues. Investors who purchased SES securities between January 29, 2025 and March 4, 2026 have until June 26, 2026 to apply as lead plaintiff.

Rosen Law Firm has filed a securities class action lawsuit against POET Technologies Inc. for allegedly making false and misleading statements regarding its tax status as a potential passive foreign investment company (PFIC), which could negatively impact U.S. shareholders. The lawsuit also alleges that defendant Thomas Mika violated a non-disclosure agreement by discussing the company's business agreements publicly. Investors who purchased POET securities between April 1, 2026 and April 27, 2026 may be eligible to join the class action with a lead plaintiff deadline of June 29, 2026.

Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies. Calix faces allegations of misleading statements regarding margin pressures from memory component costs. AeroVironment is accused of overstating business prospects amid competitive threats. Zoetis is alleged to have concealed weakening demand for key products due to safety concerns and market competition. Lucid Group is charged with failing to disclose supplier quality issues affecting vehicle deliveries. All cases have lead plaintiff deadlines in late July 2026.

Worldline held its Annual General Meeting on June 11, 2026, where shareholders approved all resolutions including financial statements, director renewals, and 2026 compensation policies. The Board restructured its committees, creating a new Technology and Transformation Committee and separate Risks Committee to support execution of the North Star 2030 strategy. The Board now comprises 12 directors with 60% independent directors and 40% women.

Worldline held its Annual General Assembly on June 11, 2026, where shareholders approved all resolutions including annual accounts for 2025 and board member renewals. The company restructured its board committees, creating a new Technology and Transformation Committee and dedicated Risk Committee to support execution of its North Star 2030 strategy focused on European payment services. The board now comprises 12 administrators with 60% independence and 40% female representation.

Rosen Law Firm has filed a class action lawsuit against ADMA Biologics, Inc. on behalf of investors who purchased securities between August 9, 2024 and March 25, 2026. The lawsuit alleges that ADMA engaged in undisclosed related party transactions, channel stuffing, lacked adequate internal controls, and made materially false statements about its business operations. Investors have until August 10, 2026 to move the court to serve as lead plaintiff.

Law Offices of Howard G. Smith has announced securities fraud class action lawsuits against four publicly-traded companies: Phreesia Inc., Sportradar Group AG, Commvault Systems Inc., and Veritone Inc. Investors have until mid-July 2026 to file lead plaintiff motions. The complaints allege various forms of misrepresentation including false growth projections, undisclosed compliance violations, misleading revenue guidance, and accounting irregularities.

Immutep Limited (IMMP) stockholders who purchased ADRs between March 24, 2025 and March 12, 2026 have until July 6, 2026 to seek lead plaintiff appointment in a securities class action. The lawsuit follows an 83% single-day stock decline after the company disclosed on March 13, 2026 that an Independent Data Monitoring Committee recommended discontinuing the TACTI-004 Phase III trial for futility.

Calix, Inc. (CALX) faces a securities class action lawsuit after disclosing on April 21, 2026 that its record gross margins were artificially inflated by dwindling pre-purchased memory components. The stock fell $6.93 per share (13.98%) following the admission. Investors who purchased CALX securities between January 28 and April 21, 2026 have until July 27, 2026 to seek lead plaintiff appointment in the class action.

FS KKR Capital Corp. (FSK) faces a securities class action lawsuit alleging management made misleading statements about credit quality improvements between May 2024 and February 2026. The company's stock fell 15.24% on February 26, 2026, following disclosure of deteriorating non-accrual rates exceeding industry averages, an $880 million combined fair value loss, and a 31% dividend cut. Investors who purchased FSK securities during the class period may be eligible for damages, with the lead plaintiff deadline set for July 6, 2026.

A securities class action has been filed against Roblox Corporation for allegedly providing misleading statements about organic growth potential while concealing material adverse facts regarding age verification rollout impacts. The company's stock declined 18.33% on May 1, 2026, following the announcement of significantly reduced bookings growth guidance (8-12%) and lower margin expectations. Investors who purchased securities between October 30, 2025 and April 30, 2026 have until August 7, 2026 to seek lead plaintiff status.

Rosen Law Firm is urging Stellantis N.V. investors who purchased stock between February 26, 2025 and February 5, 2026 to join a securities class action lawsuit before the June 8, 2026 deadline. The lawsuit alleges that Stellantis made false statements about its earnings growth potential and electrification strategy, and was not well-positioned to capitalize on EV opportunities, ultimately requiring significant charges to shift away from battery-powered electric vehicles.

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Medpace Holdings, with a June 8, 2026 deadline for lead plaintiff claims. The lawsuit alleges Medpace made false statements about backlog cancellation rates and provided misleading growth projections. Additional class actions are mentioned for Veritone, Inc. and Babcock & Wilcox Enterprises, Inc.

Rosen Law Firm has filed securities class action lawsuits against Babcock & Wilcox Enterprises, Lucid Group, and Badger Meter. The B&W lawsuit alleges the company made false statements regarding a Power Generation contract with Applied Digital, with its largest shareholder BRC standing on both sides of the deal. Investors with losses exceeding $100K are encouraged to join before the June 15, 2026 deadline.

Rosen Law Firm announces a securities class action lawsuit against Regencell Bioscience Holdings Limited for allegedly making false and misleading statements regarding market manipulation vulnerabilities and regulatory risks during the period between October 28, 2024 and October 31, 2025. Investors have until June 23, 2026 to serve as lead plaintiff.

A securities class action lawsuit has been filed against Upstart Holdings, Inc. alleging that the company made false and misleading statements about its Model 22 AI risk assessment tool. The lawsuit claims the model frequently overreacted to negative economic signals, overstating accuracy and loan approval rates, which negatively impacted revenue and made 2025 guidance unreliable. Investors who purchased UPST securities between May 14, 2025 and November 4, 2025 may be eligible for compensation. The lead plaintiff deadline is June 8, 2026.

Class action lawsuits have been filed against Calix, AeroVironment, and Zoetis for allegedly making false or misleading statements about their financial performance and business prospects. Investors have until July 27, 2026 to file lead plaintiff motions in these securities fraud cases.

Rosen Law Firm announces a securities class action lawsuit against SES AI Corporation for allegedly making materially false and misleading statements about business prospects, revenue generation, and growth projections during the period from January 29, 2025 to March 4, 2026. The lawsuit claims SES AI overstated business prospects, created artificial revenue through circular transactions, and failed to disclose material logistics constraints affecting Q4 2025 revenues. Investors have until June 26, 2026 to serve as lead plaintiff.

Rosen Law Firm is reminding investors in Upstart Holdings who purchased securities between May 14, 2025 and November 4, 2025 of an important June 8, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Upstart made false and misleading statements regarding its Model 22 AI risk assessment tool, claiming it frequently overreacted to negative economic signals, overstated accuracy, and negatively impacted revenue results, rendering the company's 2025 guidance unreliable.

Rosen Law Firm is notifying investors in Medpace Holdings, Upstart Holdings, and Babcock & Wilcox Enterprises of securities class action lawsuits. The firm alleges that Medpace made false statements about backlog cancellation rates and provided misleading growth projections. Investors with losses exceeding $100,000 are encouraged to secure counsel before the June 8, 2026 deadline to potentially serve as lead plaintiffs.

Rosen Law Firm announces a securities class action lawsuit against Babcock & Wilcox Enterprises (B&W) for allegedly making false and misleading statements regarding a Power Generation contract with Applied Digital. The lawsuit claims B&W's largest shareholder BRC Group Holdings stood on both sides of the contract and that Applied Digital did not actually need B&W's products, raising questions about revenue recognition. The lead plaintiff deadline is June 15, 2026.

A securities class action lawsuit has been filed against Stellantis N.V. for allegedly making false and misleading statements regarding its earnings growth potential and electrification strategy. The lawsuit claims the company misrepresented its ability to grow adjusted operating income and its positioning in battery-powered electric vehicles, requiring significant charges to adjust priorities. Investors who purchased stock between February 26, 2025 and February 5, 2026 may be eligible for compensation, with a June 8, 2026 deadline to serve as lead plaintiff.

Rosen Law Firm is encouraging investors with losses exceeding $100K in Regencell Bioscience Holdings Limited, Calix, Inc., and Wise Group plc to join securities class action lawsuits. The firm is seeking lead plaintiffs before the June 23, 2026 deadline. Regencell is accused of making false statements regarding market manipulation vulnerability and regulatory risks.

Tourmaline Oil Corp. announced a quarterly cash dividend of $0.50 per share payable on June 30, 2026, and held its annual shareholder meeting on June 3, 2026, where ten directors were elected. The company is Canada's largest natural gas producer focused on low-cost development in the Western Canadian Sedimentary Basin.